The WNT signaling pathway, on the other hand, increases MYC levels in patients without MYCN amplification3. Additionally, the ALK signaling pathway is the primary oncogene target pathway in sporadic and familial neuroblastoma cases4. Here, MYCN is linked to neuroblastoma.